FREE Account Opening + No Clearing Fees
Loading...

Medplus Health IPO vs Supriya Lifescience IPO

Comparision between Medplus Health IPO and Supriya Lifescience IPO.

IPO Details

Medplus Health IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Medplus Health IPO is up to ₹1,398.30 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Medplus Health IPO is ₹796.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.

  Medplus Health IPO Supriya Lifescience IPO
Face Value ₹2 per share ₹2 per share
Issue Price (Lower) ₹780.00 per share ₹265.00 per share
Issue Price (Upper) ₹796.00 per share ₹274.00 per share
Issue Price (Final) ₹796.00 per share ₹274.00 per share
Discount (Retail)
Discount (Employee) ₹78.00 per share
Market Lot Size 18 shares 54 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹600.00 Cr up to ₹200.00 Cr
OFS Issue Size
OFS Issue Size (Amount) up to ₹798.30 Cr up to ₹500.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,398.30 Cr up to ₹700.00 Cr

IPO Timetable

Medplus Health IPO opens on Dec 13, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Medplus Health IPO and Supriya Lifescience IPO is Dec 15, 2021, and Dec 20, 2021, respectively.

  Medplus Health IPO Supriya Lifescience IPO
Anchor Bid Date
Issue Open Dec 13, 2021 Dec 16, 2021
Issue Close Dec 15, 2021 Dec 20, 2021
Basis Of Allotment (Tentative) Dec 20, 2021 Dec 23, 2021
Initiation of Refunds (Tentative) Dec 21, 2021 Dec 24, 2021
Credit of Share (Tentative) Dec 22, 2021 Dec 27, 2021
Listing date (Tentative) Dec 23, 2021 Dec 28, 2021
Anchor Lockin End date 1 Jan 19, 2022 Jan 22, 2022
Anchor Lockin End date 2 Mar 20, 2022 Mar 23, 2022

Financials

Medplus Health IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .

  Medplus Health IPO Supriya Lifescience IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 17,464.94 15,656.58 13,486.96 9,587.11
Total Revenue 18,908.99 30,908.14 28,878.87 22,849.40
Profit After Tax 663.67 631.11 17.94 119.22
Summary of financial Information (Restated Standalone)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,041.02 4,458.24 3,364.01 2,530.52
Total Revenue 2,300.61 3,962.21 3,227.13 2,858.62
Profit After Tax 659.59 1,238.28 733.74 394.24
Promoter Shareholding (Pre-Issue) 43.16% 99.98%
Promoter Shareholding (Post-Issue) 40.43% 68.24%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Medplus Health IPO retail investors (RII) are offered 62,51,965 shares while in Supriya Lifescience IPO retail investors are offered 62,51,965 shares. Qualified institutional buyers (QIB) are offered 35,72,550 shares in Medplus Health IPO and 79,24,527 shares in Supriya Lifescience IPO.

  Medplus Health IPO Supriya Lifescience IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 35,72,550 shares 79,24,527 shares
NII 26,79,414 shares 39,62,263 shares
RII 62,51,965 shares 26,41,509 shares
Employee 71,225 shares 0 shares
Others
Total 1,25,75,154 shares 1,45,28,299 shares

Bids Received (Subscription)

Medplus Health IPO subscribed 52.59x in total, whereas Supriya Lifescience IPO subscribed 71.51x.

  Medplus Health IPO Supriya Lifescience IPO
QIB (times) 111.90x 31.83x
NII (times) 85.33x 161.22x
Big NII (times)
Small NII (times)
RII (times) 5.24x 56.01x
Employee (times) 3.05x
Other (times)
Total (times) 52.59x 71.51x

Comments

Add a public comment...